Empaveli Swedish Orphan Biovitrum Pty Ltd
Product name
Empaveli
Sponsor
Accepted date
Jul-2024
Active ingredients
pegcetacoplan
Proposed indication
For the treatment of paroxysmal nocturnal haemoglobinuria.
Application type
C (new indication)
Publication date
Jul-2024